Pfizer COVID Vaccine 90 Percent Effective in Trials, Company May Request Approval by End of November

Pfizer and BioNTech have said that 50 million doses of the vaccine will be produced by the end of 2020.

Pfizer COVID Vaccine 90 Percent Effective in Trials, Company May Request Approval by End of November
Pfizer and BioNTech have said that 50 million doses of the vaccine will be produced by the end of 2020.